Read + Share
Besse B, Pons-Tostivint E, Park K, Hartl S, et al. Biomarker-directed targeted therapy plus durvalumab in advanced non-small-cell
lung cancer: a phase 2 umbrella trial. Nat Med 2024 Feb 13. doi: 10.1038/s41591-024-02808.
PMID: 38351187
|
 |
|
Besse B, Pons-Tostivint E, Park K, Hartl S, et al. Biomarker-directed targeted therapy plus durvalumab in advanced non-small-cell
lung cancer: a phase 2 umbrella trial. Nat Med 2024 Feb 13. doi: 10.1038/s41591-024-02808.
PMID: 38351187
|
|
|
|